Cyril B. Gilks

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 260 publications

Coexistent Endometrial and Ovarian Carcinoma: Terminology, Clinicopathological Features, and Clinical Significance.

Coexistent Endometrial and Ovarian Carcinoma: Terminology, Clinicopathological Features, and Clinical Significance.

Journal: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
Published: April 21, 2026

Coexistent Endometrial and Fallopian Tube Carcinoma: Molecular and Pathological Features for Risk Stratification.

Coexistent Endometrial and Fallopian Tube Carcinoma: Molecular and Pathological Features for Risk Stratification.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: March 23, 2026

Recommendations for Pathologist-Led Deployment of Artificial Intelligence Tools as Laboratory-Developed Tests.

Recommendations for Pathologist-Led Deployment of Artificial Intelligence Tools as Laboratory-Developed Tests.

Journal: Laboratory investigation; a journal of technical methods and pathology
Published: February 10, 2026

Substratification of mismatch repair deficient endometrial cancers based on mechanism of MMR loss can provide prognostic and predictive refinement.

Substratification of mismatch repair deficient endometrial cancers based on mechanism of MMR loss can provide prognostic and predictive refinement.

Journal: Gynecologic oncology
Published: November 26, 2025

Retinoblastoma Protein Loss in p53 Abnormal Endometrial Carcinoma Is Associated With Poor Clinical Outcomes in a Canadian Cohort.

Retinoblastoma Protein Loss in p53 Abnormal Endometrial Carcinoma Is Associated With Poor Clinical Outcomes in a Canadian Cohort.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: September 09, 2025

Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entity.

Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entity.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 06, 2025

Outcomes Post-Laparoscopic Intervention for Accessory and Cavitated Uterine Masses: A Review and a Molecular Insight.

Outcomes Post-Laparoscopic Intervention for Accessory and Cavitated Uterine Masses: A Review and a Molecular Insight.

Journal: Gynecologic and obstetric investigation
Published: December 17, 2024

Oral contraceptive use is associated with a reduction in the physical size of fallopian tube p53 signatures.

Oral contraceptive use is associated with a reduction in the physical size of fallopian tube p53 signatures.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: November 24, 2024

Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinoma.

Activated immune infiltrates expand opportunities for targeted therapy in p53-abnormal endometrial carcinoma.

Journal: The Journal of pathology
Published: October 18, 2024

Prognostic values of molecular subtypes and SWI/SNF protein expression in de-differentiated/undifferentiated endometrial carcinoma.

Prognostic values of molecular subtypes and SWI/SNF protein expression in de-differentiated/undifferentiated endometrial carcinoma.

Journal: Histopathology
Published: September 30, 2024

Typing of Vulvar Squamous Cell Carcinoma: Why it is Important?

Typing of Vulvar Squamous Cell Carcinoma: Why it is Important?

Journal: Advances in anatomic pathology
Published: September 25, 2024

Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer management.

Serum CA125 levels in the context of ProMisE molecular classification provides pre-operative prognostic information that can direct endometrial cancer management.

Journal: Gynecologic oncology
Published: September 23, 2024
Showing 1-12 of 260

Last Updated: 09/26/2026